This trial will help researchers understand how pioglitazone helps regulate insulin in obese patients, and what role abnormal proteins in fat cells play in that process.
4 Primary · 0 Secondary · Reporting Duration: 4-9 months
Active Control
Non-Treatment Group
64 Total Participants · 4 Treatment Groups
Primary Treatment: Deferred group - pioglitazone · Has Placebo Group · Phase < 1
Age 18 - 55 · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: